Bushfire update and emergency dispensing provisions

Federal, state and territory governments have worked quickly in the past week to introduce legislation that enables those affected by the bushfire crisis to...

Updated heart failure and atrial fibrillation guidelines

New guidelines on heart failure and atrial fibrillation have been released, including new pharmacological recommendations. Released by the National Heart Foundation of Australia (NHF) in...

Australia’s youngest next to receive COVID-19 vaccine

With the COVID-19 vaccine for children aged 6 months to 5 years given the green light in the United States, Moderna’s Chief Medical Officer Dr Paul Burton expects the infant vaccine to roll out in Australia next month.

New leaders, new faces

The 2017 PSA Branch Committee elections attracted a record voter turnout of 24% up from 17% in 2014. For the first time, PSA offered...

Environmentally responsible inhaled respiratory treatments – Implications for practice

Ziqi is a regular at your pharmacy. She has popped in today to purchase a salbutamol pressurised metered dose inhaler (pMDI). You notice on her dispensing history that this will be her third in the last 4 weeks and she is overdue to have her repeat for her budesonide dry powder inhaler (DPI) filled.

Seeing more clearly

Coming soon: Greater online access for pharmacists to pathology and diagnostic imaging reports, a crucial boost for patient safety.